Close Menu

Note: This article has been updated to clarify the nature of the tumor infiltrating lymphocytes elevated in the BRCA1/2-mutated ovarian tumors.

CHICAGO (GenomeWeb) – Researchers have started tracking immune responses to different genomically defined cancer subtypes in an attempt to find those most apt to respond to immunotherapy-based treatment approaches, attendees heard here this week at the American Society of Clinical Oncology annual meeting.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

Sponsored by

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.